Zum Inhalt

HealthOSArzneimittel

Arbeitsbereiche

Nachschlagen

Wirkstoffe & Arzneimittelsicherheit

Exakte Wirkstoffkennungen und zitierbare Passagen zu Wechselwirkungen, Gegenanzeigen und Nebenwirkungen.

Ein Paarvergleich findet Originalpassagen, die den anderen Wirkstoff wörtlich nennen. Aussagen gelten für das jeweilige Präparat und seine Formulierung. Klassenbegriffe und abweichende Synonyme können fehlen. Kein Treffer bedeutet nicht, dass keine Wechselwirkung besteht.

RxNorm 05-Oct-2026 · geprüft 2026-10-26 · 1181 Präparate · 62955 Quellenpassagen · 167 strukturierte Aussagen. Automatisch aktualisiert, ohne menschliche Freigabe.

Quellenpassagen (1)

Nebenwirkungen · Ebvallo

Ebvallo 2.8 × 107 – 7.3 × 107 cells/mL dispersion for injection · Abschnitt 4.8 · PDF-Seite 8

HOS-139990 · Präparat HOS-098428

Table 2: Adverse reactions identified with Ebvallo System organ class (SOC) Adverse reaction Frequency Infections and infestations Upper respiratory tract infection Common Skin infection Common Neoplasms benign, malignant and Tumour pain Common unspecified (including cysts and Tumour flare reaction Common polyps) Blood and lymphatic system Anaemia Very common disorders Febrile neutropenia Common Immune system disorders Graft-versus-host diseasea Common Cytokine release syndrome Common Metabolism and nutrition disorders Decreased appetite Very common Hyponatraemia Very common Dehydration Very common Hypomagnesaemia Common Hypokalaemia Common Hypocalcaemia Common Psychiatric disorders Confusional state Common Delirium Common Disorientation Common Nervous system disorders Dizziness Common Headache Common Depressed level of consciousness Common Somnolence Common Peripheral sensory neuropathy Common Cardiac disorders Tachycardia Common Vascular disorders Hypotension Very common Hot flush Common Cyanosis Common Respiratory, thoracic and mediastinal Hypoxia Very common disorders Nasal congestion Very common Wheezing Common Pneumonitis Common Upper-airway cough syndrome Common Pulmonary haemorrhage Common Gastrointestinal disorders Diarrhoea Very common Nausea Very common Abdominal painb Very common Constipation Very common Colitis Common Abdominal distension Common Flatulence Common Dyschezia Common Skin and subcutaneous tissue Rashc Very common disorders Pruritus Common Skin ulcer Common Skin hypopigmentation Common Musculoskeletal and connective Muscular weakness Common tissue disorders Arthralgia Common Back pain Common Myalgia Common Arthritis Common Joint Stiffness Common Soft tissue necrosis Common General disorders and administration Pyrexia Very common site conditions Fatigue Very common Chills Common

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.

Vollständigen Kontext in der EMA-Fachinformation lesen →
Quellennachweis

Version 2026-10-02T09:37:00Z · SHA-256 b6b70030408178a0a00d53670d3028d050f247217c320de44f31caafbd3ecd0c · Passage 73dc97bfbabc2c1aa06993d8171583b77d4f0e4f094b3fa818ef1f63a3d63afb · Zeichen 1688–6495 im Abschnitt

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.